We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > ESMED

News List

GeoVax Labs Shares Jump After Presenting Early COVID-19 Vaccine Data at European Meeting firstwordpharma
August 23, 2021
Shares in GeoVax Labs were up as much as 36% Friday after the company presented data from ongoing studies of its preventive vaccine against COVID-19 at the European Society of Medicine (ESMED) general assembly, as reported in Fidelity.
GeoVax Presents COVID-19 Vaccine Data at the European Society of Medicine (ESMED) General Assembly firstwordpharma
August 20, 2021
GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology company specializing in developing human vaccines and cancer immunotherapies, today presented data from ongoing studies of its preventive vaccine against COVID-19.